Alzheimer Disease
Conditions
Keywords
Cognitive and behavioral units, Alzheimer Disease, Dementia
Brief summary
Cognitive and behavioral units (CBUs) have been created between 2008 and 2012 French National Alzheimer plan for the management of behavior problems of patients suffering from Alzheimer's disease or other related disorders and necessitating hospitalisation. This Alzheimer plan is promoting the evaluation of these units through the observation of the behavioral and psychological symptoms of dementia (BPSD) evolution. As these units are new, it appears important to assess their long-term impact on patients care.
Detailed description
EXPECTED RESULTS The present study should allow to better understand the long-term impact of CBU on care of patients with Alzheimer disease and BPSD. Moreover, it should allow to identify patients improved by CBU.
Interventions
BEHAVIORALpatients with alzheimer's disease
the Neuropsychiatric Inventory (NPI), is uded to assess 10 behavioral disturbances occurring in dementia patients: delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity. The NPI uses a screening strategy to minimize administration time, examining and scoring only those behavioral domains with positive responses to screening questions.
Sponsors
Agence Régionale de Santé Rhône-Alpes
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patient hospitalized on CBUs * patient with the diagnostic criteria for disease related to dementia stage with a Clinical Demential Rating ≥ 1 * patient with a caregiver who is fairly frequent contact with the patient in order to observe the appearance of behavior changes
Exclusion criteria
* Patient living alone at home * Patient with risk of death within one year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Neuropsychiatric Inventory (NPI) score | one year | impact of CBU effectiveness in reducing BPSD |
Secondary
| Measure | Time frame |
|---|---|
| CBU effectiveness in reducing BPSD | 6 months |
| CBU effectiveness on quality of life of patients and caregivers, and on caregivers' burden | one year |
| Psychotropic drugs (in particular neuroleptic drugs) consumption | one year |
| rehospitalisation rate for BPSD of the patients in the year following their hospitalisation in CBU | one year |
Countries
France
Outcome results
None listed